Published June 30, 2021
| Version v1
Journal article
Restricted
Beta-lapachone: Natural occurrence, physicochemical properties, biological activities, toxicity and synthesis
Authors/Creators
- 1. * & Laborat´orio de Tecnologia Dos Medicamentos, Department of Pharmaceutical Sciences, Federal University of Pernambuco, 50670-901, Av. Professor Artur de Sa´, S/n -
Description
Gomes, Camila Luiz, Sales, Victor de Albuquerque Wanderley, Melo, Camila Gomes de, Silva, Rosali Maria Ferreira da, Nishimura, Rodolfo Hideki Vicente, Rolim, Larissa Araújo, Jos, Pedro, Neto, e Rolim (2021): Beta-lapachone: Natural occurrence, physicochemical properties, biological activities, toxicity and synthesis. Phytochemistry (112713) 186: 1-8, DOI: 10.1016/j.phytochem.2021.112713, URL: http://dx.doi.org/10.1016/j.phytochem.2021.112713
Files
Restricted
The record is publicly accessible, but files are restricted. <a href="https://zenodo.org/account/settings/login?next=https://zenodo.org/records/8258675">Log in</a> to check if you have access.
Linked records
Additional details
Identifiers
- LSID
- urn:lsid:plazi.org:pub:957761705B74D35A2148911E45220328
References
- Alves, G.B.C., Lopes, R.S.C., Lopes Claudio, C., Snieckus, V., 1999. Two expedient syntheses of β- lapachone. Synthesis 1875-1877. https://doi.org/10.1055/s-1999- 3606.
- Alves, G.M.C., Rolim, L.A., Rolim Neto, P.J., Leite, A.C.L., Brondani, D.J., Medeiros, F.P. M. de, Bieber, L.W., Mendonca Junior, F.J.B., 2008. Purificactao e caracterizactao da β- lapachona e estudo de estabilidade dos cristais em diferentes condictoes de armazenamento. Quim. Nova 31, 413-416. https://doi.org/10.1590/S0100- 40422008000200039.
- Arakawa, N., Okubo, A., Yasuhira, S., Takahashi, K., Amano, H., Akasaka, T., Masuda, T., Shibazaki, M., Maesawa, C., 2018. Carnosic acid, an inducer of NAD(P)H quinone oxidoreductase 1, enhances the cytotoxicity of β- lapachone in melanoma cell lines. Oncol. Lett. 15, 2393-2400. https://doi.org/10.3892/ol.2017.7618.
- Bermejo, M., Mangas-Sanjuan, V., Gonzalez-Alvarez, I., Gonzalez-Alvarez, M., 2017. Enhancing oral absorption of β- lapachone: progress till date. Eur. J. Drug Metab. Pharmacokinet. 42, 1-10. https://doi.org/10.1007/s13318-016-0369-7.
- Bian, J., Deng, B., Zhang, X., Hu, T., Wang, N., Wang, W., Pei, H., Xu, Y., Chu, H., Li, X., Sun, H., You, Q., 2014. Lewis acid mediated highly regioselective intramolecular cyclization for the synthesis of β- lapachone. Tetrahedron Lett. 55, 1475-1478. https://doi.org/10.1016/j.tetlet.2014.01.059.
- Branco, D., de, S.C.M., Melo, C.V.S. de, Guedes, G.M. de M., Oliveira, J.S. de, Camargo, Z.P. de, Moreira, J.L.B., Monteiro, A.J., Bandeira, T., de, J.P.G., Cordeiro, R. de A., Rocha, M.F.G., Sidrim, J.J.C., 2016. Terpinen-4-ol, tyrosol, and β- lapachone as potential antifungals against dimorphic fungi. Braz. J. Microbiol. 47, 917-924. https://doi.org/10.1016/j.bjm.2016.07.015.
- Castellanos, J.R.G., Prieto, J.M., Heinrich, M., 2009. Red Lapacho (Tabebuia impetiginosa) - a global ethnopharmacological commodity? J. Ethnopharmacol. 121, 1-13. https://doi.org/10.1016/j.jep.2008.10.004.
- Cavalcanti, I.M.F., Pontes-Neto, J.G., Kocerginsky, P.O., Bezerra-Neto, A.M., Lima, J.L.C., Lira-Nogueira, M.C.B., Maciel, M.A.V., Neves, R.P., Pimentel, M.F., Santos- Magalhtaes, N.S., 2015. Antimicrobial activity of β- lapachone encapsulated into liposomes against meticillin-resistant Staphylococcus aureus and Cryptococcus neoformans clinical strains. J. Glob. Antimicrob. Resist. 3, 103-108. https://doi.org/ 10.1016/j.jgar.2015.03.007.
- Choi, W.H., Ahn, J., Jung, C.H., Jang, Y.J., Ha, T.Y., 2016. β- Lapachone prevents dietinduced obesity by increasing energy expenditure and stimulating the browning of white adipose tissue via downregulation of miR-382 expression. Diabetes 65, 2490-2501. https://doi.org/10.2337/db15-1423.
- Choi, Y.-H., Kang, H.-S., Yoo, M.-A., 2003. Suppression of human prostate cancer cell growth by β- lapachone via down-regulation of pRB phosphorylation and induction of Cdk inhibitor p21WAF1/CIP1. J. Biochem. Mol. Biol. 36, 223-229. https://doi. org/10.5483/BMBRep.2003.36.2.223.
- Claessens, S., Habonimana, P., De Kimpe, N., 2010. Synthesis of naturally occurring naphthoquinone epoxides and application in the synthesis of β- lapachone. Org. Biomol. Chem. 8, 3790-3795. https://doi.org/10.1039/c004580b.
- Coelho, T.S., Silva, R.S.F., Pinto, A.V., Pinto, M.C.F.R., Scaini, C.J., Moura, K.C.G., Almeida da Silva, P., 2010. Activity of β- lapachone derivatives against rifampicinsusceptible and -resistant strains of Mycobacterium tuberculosis. Tuberculosis 90, 293-297. https://doi.org/10.1016/j.tube.2010.06.001.
- da Costa, D.C.F., Rangel, L.P., Martins-Dinis, M.M.D., da, C., Ferretti, G.D. da S., Ferreira, V.F., Silva, J.L., 2020. Anticancer potential of resveratrol, β- lapachone and their analogues. Molecules 25, 893. https://doi.org/10.3390/molecules25040893.
- da Silva, F.C., Ferreira, V.F., 2016. Natural naphthoquinones with great importance in medicinal chemistry. Curr. Org. Synth. 13, 334-371. https://doi.org/10.2174/ 1570179412666150817220343.
- da Silva, M.N., Ferreira, V.F., Souza, M.C.B., de, V., 2003. Um panorama atual da quimica e da farmacologia de naftoquinonas, com ˆenfase na β- lapachona e derivados. Quim. Nova 26, 407-416. https://doi.org/10.1590/S0100- 40422003000300019.
- de Almeida, E.R., Lucena, F.R.S., Silva, C.V.N.S., da Silva Costa-Junior, W., Cavalcanti, J. B., Couto, G.B.L., da Silva, L.L.S., da Mota, D.L., da Silveira, A.B., de Sousa Filho, S. D., da Silva, A.C.P., 2009. Toxicological assessment of beta-lapachone on organs from pregnant and non-pregnant rats. Phyther. Res. 23, 1276-1280. https://doi.org/ 10.1002/ptr.2646.
- Delarmelina, M., Nicoletti, C.D., de Moraes, M.C., Futuro, D.O., Buhl, M., da Silva, F.C., Ferreira, V.F., Carneiro, J.W.M., 2019. α- and β- Lapachone isomerization in acidic media: insights from experimental and implicit/explicit solvation approaches. Chempluschem 84, 52-61. https://doi.org/10.1002/cplu.201800485.
- Dias, R.B., de Araujo, T.B.S., de Freitas, R.D., Rodrigues, A.C.B., da, C., Sousa, L.P., Sales, C.B.S., Valverde, L. de F., Soares, M.B.P., dos Reis, M.G., Coletta, R., Della Ramos, E.A.G., Camara, C.A., Silva, T.M.S., Filho, J.M.B., Bezerra, D.P., Rocha, C.A. G., 2018. β- Lapachone and its iodine derivatives cause cell cycle arrest at G2/M phase and reactive oxygen species-mediated apoptosis in human oral squamous cell carcinoma cells. Free Radic. Biol. Med. 126, 87-100. https://doi.org/10.1016/j. freeradbiomed.2018.07.022.
- Du, L., Li, M.-D., Zhang, Y., Xue, J., Zhang, X., Zhu, R., Cheng, S.C., Li, X., Phillips, D.L., 2015. Photoconversion of β- lapachone to α- lapachone via a protonation-assisted singlet excited state pathway in aqueous solution: a time-resolved spectroscopic study. J. Org. Chem. 80, 7340-7350. https://doi.org/10.1021/acs.joc.5b00086.
- Ettlinger, M.G., 1950. Hydroxynaphthoquinones. II. Cyclization and the basicity and interconversion of ortho and para quinones. J. Am. Chem. Soc. 72, 3090-3095. https://doi.org/10.1021/ja01163a080.
- Fernandes, A.W.C., dos Anjos Santos, V.L., Araujo, C.R.M., de Oliveira, H.P., da Costa, M. M., 2020. Anti-biofilm effect of β- lapachone and lapachol oxime against isolates of Staphylococcus aureus. Curr. Microbiol. 77, 204-209. https://doi.org/10.1007/ s00284-019-01818-1.
- Fu, S.-C., Chau, Y.-P., Lu, K.-S., Kung, H.-N., 2011. β- Lapachone accelerates the recovery of burn-wound skin. Histol. Histopathol. 26, 905-914. https://doi.org/10.14670/ HH-26.905.
- Furuya, Y., Ohta, S., Ito, H., 1997. Apoptosis of androgen-independent mammary and prostate cell lines induced by topoisomerase inhibitors: common pathway of gene regulation. Anticancer Res. 17, 2089-2093. PMID: 9216669.
- Garavaglia, P.A., Rubio, M.F., Laverri`ere, M., Tasso, L.M., Fichera, L.E., Cannata, J.J.B., Garcia, G.A., 2018. Trypanosoma cruzi : death phenotypes induced by ortho -naphthoquinone substrates of the aldo-keto reductase (Tc AKR). Role of this enzyme in the mechanism of action of β -lapachone. Parasitology 145, 1251-1259. https:// doi.org/10.1017/S0031182018000045.
- Gerber, D.E., Beg, M.S., Fattah, F., Frankel, A.E., Fatunde, O., Arriaga, Y., Dowell, J.E., Bisen, A., Leff, R.D., Meek, C.C., Putnam, W.C., Kallem, R.R., Subramaniyan, I., Dong, Y., Bolluyt, J., Sarode, V., Luo, X., Xie, Y., Schwartz, B., Boothman, D.A., 2018. Phase 1 study of ARQ 761, a β- lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis. Br. J. Canc. 119, 928-936. https://doi.org/ 10.1038/s41416-018-0278-4.
- Gu, D.R., Lee, J.N., Oh, G.-S., Kim, H.J., Kim, M.S., Lee, S.H., 2017. The inhibitory effect of beta-lapachone on RANKL-induced osteoclastogenesis. Biochem. Biophys. Res. Commun. 482, 1073-1079. https://doi.org/10.1016/j.bbrc.2016.11.160.
- Hooker, S.C., 1936. The constitution of lapachol and its derivatives. Part V. The structure of Patern`o' s "Isolapachone. J. Am. Chem. Soc. 58, 1190-1197. https://doi.org/ 10.1021/ja01298a033.
- Huang, L., Pardee, A.B., 1999. β- Lapachone induces cell cycle arrest and apoptosis in human colon cancer cells. Mol. Med. 5, 711-720. PMID: 10656873.
- Huang, X., Motea, E.A., Moore, Z.R., Yao, J., Dong, Y., Chakrabarti, G., Kilgore, J.A., Silvers, M.A., Patidar, P.L., Cholka, A., Fattah, F., Cha, Y., Anderson, G.G., Kusko, R., Peyton, M., Yan, J., Xie, X.-J., Sarode, V., Williams, N.S., Minna, J.D., Beg, M., Gerber, D.E., Bey, E.A., Boothman, D.A., 2016. Leveraging an NQO1 bioactivatable drug for tumor-selective use of poly(ADP-ribose) polymerase inhibitors. Canc. Cell 30, 940-952. https://doi.org/10.1016/j.ccell.2016.11.006.
- Hussain, H., Green, I.R., 2017. Lapachol and lapachone analogs: a journey of two decades of patent research (1997-2016). Expert Opin. Ther. Pat. 27, 1111-1121. https://doi. org/10.1080/13543776.2017.1339792.
- Jeong, M.H., Tran, N.K.S., Kwak, T.H., Park, B.K., Lee, C.S., Park, T.-S., Lee, Y.-H., Park, W.J., Yang, D.K., 2014. β- Lapachone ameliorates lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice. PloS One 9, e91039. https://doi.org/10.1371/ journal.pone.0091039.
- Kee, J.-Y., Han, Y.-H., Park, J., Kim, D.-S., Mun, J.-G., Ahn, K.S., Kim, H.-J., Um, J.-Y., Hong, S.-H., 2017. β- Lapachone inhibits lung metastasis of colorectal cancer by inducing apoptosis of CT26 cells. Integr. Canc. Ther. 16, 585-596. https://doi.org/ 10.1177/1534735416681638.
- Kim, D., Cho, J.-Y., 2018. NQO1 is required for β- lapachone-mediated downregulation of breast-cancer stem-cell activity. Int. J. Mol. Sci. 19, 3813. https://doi.org/10.3390/ ijms19123813.
- Kim, I., Kim, H., Ro, J., Jo, K., Karki, S., Khadka, P., Yun, G., Lee, J., 2015. Preclinical pharmacokinetic evaluation of β- lapachone: characteristics of oral bioavailability and first-pass metabolism in rats. Biomol. Ther. (Seoul). 23, 296-300. https://doi. org/10.4062/biomolther.2015.029.
- Kim, K.H., Oh, H.K., Heo, B., Kim, N.A., Lim, D.G., Jeong, S.H., 2018. Solubility evaluation and thermodynamic modeling of β- lapachone in water and ten organic solvents at different temperatures. Fluid Phase Equil. 472, 1-8. https://doi.org/ 10.1016/j.fluid.2018.05.005.
- Kim, K.H., Park, S.-H., Adhikary, P., Cho, J.H., Kang, N.-G., Jeong, S.H., 2016. Stability of β- lapachone upon exposure to various stress conditions: resultant efficacy and cytotoxicity. Chem. Pharm. Bull. 64, 381-389. https://doi.org/10.1248/cpb.c15- 00706.
- Kung, H.-N., Yang, M.-J., Chang, C.-F., Chau, Y.-P., Lu, K.-S., 2008. In vitro and in vivo wound healing-promoting activities of β- lapachone. Am. J. Physiol. Physiol. 295, C931-C943. https://doi.org/10.1152/ajpcell.00266.2008.
- Lamberti, M.J., Rumie Vittar, N.B., de Carvalho da Silva, F., Ferreira, V.F., Rivarola, V.A., 2013. Synergistic enhancement of antitumor effect of β- lapachone by photodynamic induction of quinone oxidoreductase (NQO1). Phytomedicine 20, 1007-1012. https://doi.org/10.1016/j.phymed.2013.04.018.
- Lee, E.-J., Ko, H.-M., Jeong, Y.-H., Park, E.-M., Kim, H.-S., 2015. β- Lapachone suppresses neuroinflammation by modulating the expression of cytokines and matrix metalloproteinases in activated microglia. J. Neuroinflammation 12, 133. https:// doi.org/10.1186/s12974-015-0355-z.
- Lee, M., Ban, J.-J., Chung, J.-Y., Im, W., Kim, M., 2018. Amelioration of Huntington' s disease phenotypes by Beta-Lapachone is associated with increases in Sirt1 expression, CREB phosphorylation and PGC-1α deacetylation. PloS One 13, e0195968. https://doi.org/10.1371/journal.pone.0195968.
- Li, C.J., Averboukh, L., Pardee, A.B., 1993a. β- Lapachone, a novel DNA topoisomerase I inhibitor with a mode of action different from camptothecin*. J. Biol. Chem. 268, 22463-22468. PMID: 8226754.
- Li, C.J., Wang, C., Pardee, A.B., 1995. Induction of apoptosis by β- lapachone in human prostate cancer cells. Canc. Res. 55, 3712-3715. PMID: 7641181.
- Li, C.J., Zhang, L.J., Dezube, B.J., Crumpacker, C.S., Pardee, A.B., 1993b. Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc. Natl. Acad. Sci. Unit. States Am. 90, 1839-1842. https://doi.org/10.1073/pnas.90.5.1839.
- Liu, S.-H., Tzeng, H.-P., Kuo, M.-L., Lin-Shiau, S.-Y., 1999. Inhibition of inducible nitric oxide synthase by β- lapachone in rat alveolar macrophages and aorta. Br. J. Pharmacol. 126, 746-750. https://doi.org/10.1038/sj.bjp.0702341.
- Lu, C.Y., 2014. β- Lapachone ameliorates murine cisplatin nephrotoxicity: NAD+, NQO1, and SIRT1 at the crossroads of metabolism, injury, and inflammation. Kidney Int. 85, 496-498. https://doi.org/10.1038/ki.2013.419.
- Mandinova, A., Lee, S.W., 2011. The p53 pathway as a target in cancer therapeutics: obstacles and promise. Sci. Transl. Med. 3 https://doi.org/10.1126/ scitranslmed.3001366, 64rv1-64rv1.
- Mangas-Sanjuan, V., Guti´errez-Nieto, J., Echezarreta-L´opez, M., Gonz´alez-Alvarez ´, I., Gonz´alez-Alvarez ´, M., Casab´o, V.-G., Bermejo, M., Landin, M., 2016. Intestinal permeability of β- lapachone and its cyclodextrin complexes and physical mixtures. Eur. J. Drug Metab. Pharmacokinet. 41, 795-806. https://doi.org/10.1007/s13318- 015-0310-5.
- Mata-Santos, T., Pinto, N.F., Mata-Santos, H.A., de Moura, K.G., Carneiro, P.F., Carvalho, T., dos, S., del Rio, K.P., Pinto, M., do, C.F.R., Martins, L.R., Fenalti, J.M., da Silva, P.E.A., Scaini, C.J., 2015. Anthelmintic activity of lapachol, β- lapachone and its derivatives against Toxocara canis larvae. Rev. Inst. Med. Trop. Sao Paulo 57, 197-204. https://doi.org/10.1590/S0036-46652015000300003.
- Miao, X.-S., Song, P., Savage, R.E., Zhong, C., Yang, R.-Y., Kizer, D., Wu, H., Volckova, E., Ashwell, M.A., Supko, J.G., He, X., Chan, T.C.K., 2008. Identification of the in vitro metabolites of 3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2- b]pyran-5,6-dione (ARQ 501; β- lapachone) in whole blood. Drug Metab. Dispos. 36, 641-648. https://doi. org/10.1124/dmd.107.018572.
- Moon, D.-O., Choi, Y.H., Kim, N.-D., Park, Y.-M., Kim, G.-Y., 2007. Anti-inflammatory effects of β- lapachone in lipopolysaccharide-stimulated BV2 microglia. Int. Immunopharm. 7, 506-514. https://doi.org/10.1016/j.intimp.2006.12.006.
- Moraes, D.C., Curvelo, J.A.R., Anjos, C.A., Moura, K.C.G., Pinto, M.C.F.R., Portela, M.B., Soares, R.M.A., 2018. β- lapachone and α- nor-lapachone modulate Candida albicans viability and virulence factors. J. Mycol. Med. 28, 314-319. https://doi.org/ 10.1016/j.mycmed.2018.03.004.
- Moreno, E., Schwartz, J., Larrea, E., Conde, I., Font, M., Sanmartin, C., Irache, J.M., Espuelas, S., 2015. Assessment of β- lapachone loaded in lecithin-chitosan nanoparticles for the topical treatment of cutaneous leishmaniasis in L. major infected BALB/c mice. Nanomed. Nanotechnol. Biol. Med. 11 https://doi.org/ 10.1016/j.nano.2015.07.011, 2003-2012.
- Nukuzuma, S., Nakamichi, K., Kameoka, M., Sugiura, S., Nukuzuma, C., Tasaki, T., Takegami, T., 2016. Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells. Microbiol. Immunol. 60, 253-260. https://doi.org/10.1111/1348-0421.12372.
- Lopes, N., Tallarico Pupo, M., da Silva Emery, F., dos Santos Goncalves, N., Alves dos Santos, R., Jacometti Cardoso Furtado, N.A., 2017. Inactivation of β- lapachone cytotoxicity by filamentous fungi that mimic the human blood metabolism. Eur. J. Drug Metab. Pharmacokinet. 42, 213-220. https://doi.org/10.1007/s13318-016- 0337-2.
- Park, J.-S., Lee, Y.-Y., Kim, J., Seo, H., Kim, H.-S., 2016a. β- Lapachone increases phase II antioxidant enzyme expression via NQO1-AMPK/PI3K-Nrf2/ARE signaling in rat primary astrocytes. Free Radic. Biol. Med. 97, 168-178. https://doi.org/10.1016/j. freeradbiomed.2016.05.024.
- Park, J.-S., Leem, Y.-H., Park, J.-E., Kim, D.-Y., Kim, H.-S., 2019. Neuroprotective effect of β- lapachone in MPTP-induced Parkinson' s disease mouse model: involvement of astroglial p-AMPK/Nrf2/HO-1 signaling pathways. Biomol. Ther. (Seoul). 27, 178-184. https://doi.org/10.4062/biomolther.2018.234.
- Park, S.-H., Jeong, S.H., Kim, S.-W., 2016b. β- Lapachone regulates the transforming growth factor-β-smad signaling pathway associated with collagen biosynthesis in human dermal fibroblasts. Biol. Pharm. Bull. 39, 524-531. https://doi.org/10.1248/ bpb.b15-00730.
- Pereira, E.M., Machado, T.B., Leal, I.C.R., Jesus, D.M., Damaso, C.R.A., Pinto, A.V., Giambiagi-deMarval, M., Kuster, R.M., dos Santos, K.R.N., 2006. Tabebuia avellanedae naphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivo dermal irritability analysis. Ann. Clin. Microbiol. Antimicrob. 5, 5. https://doi.org/10.1186/1476-0711-5-5.
- Planchon, S.M., Wuerzberger, S., Frydman, B., Witiak, D.T., Hutson, P., Church, D.R., Wilding, G., Boothman, D.A., 1995. β- Lapachone-mediated apoptosis in human promyelocytic leukemia (HL-60) and human prostate cancer cells: a p53- independent response. Canc. Res. 55, 3706-3711. PMID: 7641180.
- Salas, C., Tapia, R.A., Ciudad, K., Armstrong, V., Orellana, M., Kemmerling, U., Ferreira, J., Maya, J.D., Morello, A., 2008. Trypanosoma cruzi: activities of lapachol and α- and β- lapachone derivatives against epimastigote and trypomastigote forms. Bioorg. Med. Chem. 16, 668-674. https://doi.org/10.1016/j.bmc.2007.10.038.
- Salas, C.O., Faundez, M., Morello, A., Diego Maya, J., Tapia, R.A., 2011. Natural and synthetic naphthoquinones active against Trypanosoma cruzi: an initial step towards new drugs for Chagas disease. Curr. Med. Chem. 18, 144-161. https://doi.org/ 10.2174/092986711793979779.
- Marandi, Y., Roshangar, L., Bahrambeigi, S., Mesgari-Abbasi, M., 2019. β- Lapachone protects against doxorubicin-induced nephrotoxicity via NAD+/AMPK/NF-kB in mice. Naunyn-Schmiedeberg' s Arch. Pharmacol. 392, 633-640. https://doi.org/ 10.1007/s00210-019-01619-0.
- Schuerch, A.R., Wehrli, W., 1978. β- Lapachone, an inhibitor of oncornavirus reverse transcriptase and eukaryotic DNA polymerase-α. Inhibitory effect, thiol dependency and specificity. Eur. J. Biochem. 84, 197-205. https://doi.org/10.1111/j.1432- 1033.1978.tb12157.x.
- Silvers, M.A., Deja, S., Singh, N., Egnatchik, R.A., Sudderth, J., Luo, X., Beg, M.S., Burgess, S.C., DeBerardinis, R.J., Boothman, D.A., Merritt, M.E., 2017. The NQO1 bioactivatable drug, β- lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism. J. Biol. Chem. 292, 18203-18216. https://doi.org/10.1074/jbc.M117.813923.
- Tseng, C.-H., Cheng, C.-M., Tzeng, C.-C., Peng, S.-I., Yang, C.-L., Chen, Y.-L., 2013. Synthesis and anti-inflammatory evaluations of β- lapachone derivatives. Bioorg. Med. Chem. 21, 523-531. https://doi.org/10.1016/j.bmc.2012.10.047.
- Wuerzberger, S.M., Pink, J.J., Planchon, S.M., Byers, K.L., Bornmann, W.G., Boothman, D.A., 1998. Induction of apoptosis in MCF-7:WS8 breast cancer cells by β- Lapachone. Canc. Res. 58, 1876-1885. PMID: 9581828.
- Xu, J., Wagoner, G., Douglas, J.C., Drew, P.D., 2013. β- Lapachone ameliorization of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 254, 46-54. https://doi.org/10.1016/j.jneuroim.2012.09.004.
- Yang, Y., Zhou, X., Xu, M., Piao, J., Zhang, Y., Lin, Z., Chen, L., 2017. β- lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers. Sci. Rep. 7, 2681. https://doi.org/10.1038/s41598- 017-02937-0.